Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $6.83 in the prior trading day, LifeMD Inc (NASDAQ: LFMD) closed at $6.89, up 0.88%. In other words, the price has increased by $0.88 from its previous closing price. On the day, 2.0 million shares were traded. LFMD stock price reached its highest trading level at $6.89 during the session, while it also had its lowest trading level at $6.6.
Ratios:
Our goal is to gain a better understanding of LFMD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.26. For the most recent quarter (mrq), Quick Ratio is recorded 0.72 and its Current Ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Schreiber Justin sold 25,000 shares for $9.99 per share. The transaction valued at 249,690 led to the insider holds 2,475,721 shares of the business.
Justin Schreiber bought 175,000 shares of LFMD for $1,821,750 on Aug 01 ’25. On Jul 01 ’25, another insider, Schreiber Justin, who serves as the Chairman and CEO of the company, sold 25,000 shares for $13.38 each. As a result, the insider received 334,458 and left with 2,500,721 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 326705888 and an Enterprise Value of 311850496. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.33. Its current Enterprise Value per Revenue stands at 1.27 whereas that against EBITDA is -840.511.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.58, which has changed by 0.35897434 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.99. The 50-Day Moving Average of the stock is -39.89%, while the 200-Day Moving Average is calculated to be -8.40%.
Shares Statistics:
The stock has traded on average 2.07M shares per day over the past 3-months and 4238340 shares per day over the last 10 days, according to various share statistics. A total of 45.04M shares are outstanding, with a floating share count of 37.94M. Insiders hold about 19.98% of the company’s shares, while institutions hold 39.13% stake in the company. Shares short for LFMD as of 1753920000 were 4425226 with a Short Ratio of 2.14, compared to 1751241600 on 4045071. Therefore, it implies a Short% of Shares Outstanding of 4425226 and a Short% of Float of 11.93.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of LifeMD Inc (LFMD) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.04, with high estimates of $0.11 and low estimates of -$0.04.
Analysts are recommending an EPS of between $0.48 and -$0.13 for the fiscal current year, implying an average EPS of $0.17. EPS for the following year is $0.45, with 2.0 analysts recommending between $0.79 and $0.11.
Revenue Estimates
8 analysts predict $62.07M in revenue for the current quarter. It ranges from a high estimate of $62.65M to a low estimate of $61M. As of the current estimate, LifeMD Inc’s year-ago sales were $53.39MFor the next quarter, 8 analysts are estimating revenue of $63.07M. There is a high estimate of $64.6M for the next quarter, whereas the lowest estimate is $62.33M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $255M, while the lowest revenue estimate was $251.9M, resulting in an average revenue estimate of $253.07M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $297.14M in the next fiscal year. The high estimate is $305.14M and the low estimate is $285.8M.
